Danaher to Buy Beckman Coulter for $6.8B

BREA, California ( TheStreet) -- Danaher ( DHR) reached an agreement to buy Beckman Coulter ( BEC), a maker of biomedical testing equipment, for $83.50 a share in cash, or about $6.8 billion including assumed debt.

The purchase price is a 46% premium over Beckman Coulter's closing price of $57.09 on Dec. 9, 2010, before rumors of an acquisition first surfaced, the companies said in a statement Monday.

The transaction is expected to be completed in the first half of 2011.

-- Written by Joseph Woelfel

>To contact the writer of this article, click here: Joseph Woelfel

>To submit a news tip, send an email to: tips@thestreet.com.

More from Stocks

Stocks Trade Mixed Amid Progress on U.S.-China Trade; Dow Turns Lower

Stocks Trade Mixed Amid Progress on U.S.-China Trade; Dow Turns Lower

Micron Shares Soar; Chipmaker Is 'Managing for Profitability' Now, Says Analyst

Micron Shares Soar; Chipmaker Is 'Managing for Profitability' Now, Says Analyst

Big Banks' Shift to Digital Could Bring These Significant Shareholder Benefits

Big Banks' Shift to Digital Could Bring These Significant Shareholder Benefits

Red Hot Micron Is Still One Heck of a Bargain

Red Hot Micron Is Still One Heck of a Bargain

Stacey Cunningham: From Intern to Head of the New York Stock Exchange

Stacey Cunningham: From Intern to Head of the New York Stock Exchange